-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
January 01, 2011 - What are the adverse effects or harms associated with
testing using newer and/or older markers of iron … Studies did not attribute these deaths to either
testing or treatment. … What are the adverse
effects or harms
associated with
testing using newer
and/or older markers
of … Studies did not attribute these deaths to either
testing or any treatment. … A randomized trial of iron
deficiency testing strategies in hemodialysis patients.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
December 31, 2022 - What are the unintended consequences of
antibody testing after SARS-CoV-2 infection? … Currently, the most salient use of antibody testing is as a correlate of protection against
infection … This review does not address all potential uses of antibody testing in clinical practice. … Most
notably, this review does not address the use of antibody testing for the diagnosis of SARS-CoV … Current Testing Strategies for SARS-CoV-2 in
the United States.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-infection-prevention-mdro-protocol.pdf
July 01, 2023 - environments, including those centering around the patient
microbiome (including MDRO surveillance testing … Safer II (2013) chapter 7 included barrier isolation
precautions while adding routine surveillance testing … hospital populations (such as all intensive care unit [ICU]
patients) regardless of surveillance testing … Population Adult patients (18+ years) Pediatric patients (under 18 years)
Intervention • Surveillance testing … or alternative transmission-based
precautions
N/A
Outcome • Clinical outcomes
o Surveillance testing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
November 01, 2019 - O= Order, C= Consider, D= Diagnosis, M= Monitor, L= Laboratory Testing, R= Recommendation
Task 2. … In the software development lifecycle, this stage of testing is often referred to as “black
box” testing … The CDS Connect Authoring Tool provides
support for unit testing (testing of combinations of patient … We recommend that AHRQ consider
developing an EHR testing environment to facilitate testing and quality … Extent of Adherence to Trustworthy Standards
(NEATS) InstrumentDeveloping and Testing
NEATS.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-machine-learning-screening.pdf
November 01, 2019 - Screening Exercise for the User Experiences Testing
Appendix B. … Key differences
between the tools played an important role in the user experience testing by exposing … We received ethical approval to complete the user experience testing
from the University of Alberta … Before beginning the user experience testing, the screening exercise and survey were pilot
tested by … Screening Exercise for the User Experiences Testing
Screening Exercise
Instructions for Each Tool
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
January 08, 2013 - CER #50:
Antinuclear Antibody, Rheumatoid Factor, and
Cyclic-Citrullinated Peptide Tests for Evaluating
Musculoskeletal Complaints in Children
Original release date:
March, 2012
Surveillance Report:
March, 2013
Key Findings:
- All conclusions from the original CER are up to date.
Summary Decisio…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
March 01, 2012 - 1
Comparative Effectiveness Review
Number 50
Antinuclear Antibody, Rheumatoid Factor, and
Cyclic-Citrullinated Peptide Tests for Evaluating
Musculoskeletal Complaints in Children
Executive Summary
Background
Musculoskeletal (MSK) pain is common
in children and adolescents, with an
estimated prevalence rangin…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guide-editorial_methods.pdf
July 01, 2012 - compared to a reference standard, in this case, invasive
angiography) and the downstream result of testing
-
effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - Overall High Impact Potential: Xpert MTB/RIF test for detection and drug sensitivity
testing of M. … Susceptibility to other agents would still have to be guided by traditional
testing methods. … , which could lead to decentralization
of testing, some experts thought. … Molecular-based diagnostic
testing for clostridium difficile. … Targeted testing and the diagnosis of latent
tuberculosis infection and tuberculosis disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_disposition-comments.pdf
January 27, 2016 - The sentences about POC
testing are impossible to understand. Please
revise. … Edited sentences about POC
testing to improve clarity.
74. … CRP testing is referred to several times
throughout the CER. … You
write S. pneumococcal Point-of-care testing
(Rapid Strep Test). … The classification of 'rapid strep" testing as
testing for Streptococcus pneumoniae is
incorrect.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-mobile-apps-disposition-of-comments.pdf
May 20, 2022 - Pilot testing with 10 apps is inadequate (possible bias in app selection);
more detail is needed on … The section on pilot testing has been revised based on results from further rounds of
testing. … The final report describes the pre-pilot test of 10 apps and six rounds of
dual-review pilot testing … We
have reported the interrater reliability for the additional rounds of pilot testing, which
is … However,
during the pilot testing
phase, we were unable
to test the framework on
apps that could
-
effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
January 01, 2012 - Overall High Impact Potential: Xpert MTB/RIF test for detection and drug
sensitivity testing of M. … Susceptibility to other agents would still have to be guided by traditional testing
methods. … Susceptibility to other agents would still have to be guided by traditional testing
methods. … , which could lead to
decentralization of testing, some experts thought. … Targeted testing and the diagnosis of latent
tuberculosis infection and tuberculosis disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-abnormalities-tests-update_research-protocol.pdf
July 01, 2010 - Positive predictive value: the probability of a woman actually having breast
cancer after testing positive … Negative predictive value: the probability of a woman actually not having breast
cancer after testing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-informed-care-executive-summary.pdf
January 01, 2025 - Another consideration when testing
a full system of TIC is the availability of a sufficient number of … understanding of how singular intervention components interact to influence key
outcomes prior to efficacy testing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-disposition-comments.pdf
May 14, 2025 - May 14, 2025
7
Commentator and
Affiliation Section Comment Response
about harms of additional testing … demonstrated to yield a favorable positive
predictive value in the 43-44% range (also a
product of testing … Rationale: The inherent value of MCED
testing is in its ability to detect a broad range
of cancers. … Exact Sciences’ Response: When
considering harms associated with MCSTs
or additional testing following … Rationale: Potential harms of MCED testing
are primarily related to the risk of false-
positive results
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_research-protocol.pdf
December 23, 2014 - The testing
strategies used in hospitals are rapidly evolving. … However, given the rapid evolution of testing
strategies, studies of diagnostic test performance often … Since there has been some growth in the diagnostic testing literature, and diagnostic
testing continues … Does testing strategy impact patient health or health system outcomes? … Framework for diagnostic testing and treatment
Source: www.effectivehealthcare.ahrq.gov
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
March 01, 2017 - This threshold also
may be defined based upon formal cognitive testing scores
below norms for younger … These theories support prevention trials testing
cognitive training, physical exercise, cardiovascular … functional abnormalities earlier or with greater
sensitivity than is possible with behavior-based testing … In other cases, theories of brain
function (e.g., neuroplasticity) justify the development
and testing … The substantial work on modifiable risk factors would
be better informed by testing interventions that
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
March 01, 2017 - This threshold also
may be defined based upon formal cognitive testing scores
below norms for younger … These theories support prevention trials testing
cognitive training, physical exercise, cardiovascular … functional abnormalities earlier or with greater
sensitivity than is possible with behavior-based testing … In other cases, theories of brain
function (e.g., neuroplasticity) justify the development
and testing … The substantial work on modifiable risk factors would
be better informed by testing interventions that
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-health-care-practice-delivery.pdf
November 01, 2022 - , treatments for depression, management of opioid overdose)
◆ Diagnostic tests (e.g., noninvasive testing
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
September 21, 2012 - If we make a Bonferroni correction
for multiple testing in order to maintain the correct
Type-I error … biological
and epidemiological evidence; detailed description
of a statistical analysis plan for how testing … achieve Possible Difficult to characterize
sampling properties (e.g.,
confidence intervals)
Power of testing … To do this,
chance findings should be evaluated by testing for
interaction; biases should be avoided … - Describe methods to adjust for multiple testing, if
applicable. o
Describe how confounding